Chuba J V, Kuhns W J, Oppenheim J D, Nachbar M S, Nigrelli R F
Immunology. 1975 Jul;29(1):17-30.
Purified blood group-active substances derived from different pig, horse, baboon, Rhesus monkey and human tissues were quantitatively studied for their haemagglutination inhibiting potency with: (1) human IgM anti-A and anti-B; (2) human anti-Lea and anti-Leb; (3) Ulex europaeus extracts separated into lectin fractions with respective L-fucose-inhibitable ('anti-HF') and chitobiose-cellobiose-inhibitable ('anti-HC') combining sites. Irrespective of species origin, A and B blood group activity per milligram of purified material tended to be strikingly higher in substances low in, or devoid of, Lewis blood group activity. Most of the blood group substances displayed variable but about equally balanced amounts of Ulex anti-HF and anti-HC inhibiting activity. In contrast, pig submaxillary gland mucins displayed strikingly high levels of Ulex anti-HC inihibiting activity, even in the complete absence of Ulex anti-HF inhibiting activity. These serological findings are consistent with current biochemical concepts regarding the heterosaccharide microheterogeneity of blood group-active glycoproteins.
对源自不同猪、马、狒狒、恒河猴和人类组织的纯化血型活性物质进行了定量研究,以考察它们对以下物质的血凝抑制效力:(1) 人IgM抗A和抗B;(2) 人抗Lea和抗Leb;(3) 欧洲荆豆提取物,分离成具有各自L-岩藻糖抑制性(“抗HF”)和壳二糖-纤维二糖抑制性(“抗HC”)结合位点的凝集素组分。无论物种来源如何,每毫克纯化物质的A和B血型活性在Lewis血型活性低或缺乏的物质中往往显著更高。大多数血型物质表现出可变但大致平衡的欧洲荆豆抗HF和抗HC抑制活性。相比之下,猪颌下腺粘蛋白即使在完全没有欧洲荆豆抗HF抑制活性的情况下,也表现出显著高水平的欧洲荆豆抗HC抑制活性。这些血清学发现与当前关于血型活性糖蛋白异糖微异质性的生化概念一致。